3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
CNS
1
Conditions
Neoplasms
2
Brain Neoplasms
2
Sarcoma
1
Pituitary Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Hodgkin Disease
1
Glioma
1
Fatigue
1
Cytokine Release Syndrome
1
Astrocytoma
1
Interventions
Magnetic Resonance Spectroscopy
16
Blood Specimen Collection
8
Temozolomide
5
Magnetic Resonance Imaging
5
Bevacizumab
4
Yoga
3
Radiotherapy, Intensity-Modulated
3
Biopsy
3
Transcranial Magnetic Stimulation
2
Surveys and Questionnaires
2
Restraint, Physical
2
Radiosurgery
2
Radiation
2
Psychosocial Intervention
2
Proton Therapy
2
Physical Therapy Modalities
2
Palliative Care
2
Mind-Body Therapies
2
Mental Status and Dementia Tests
2
Heart Rate
2
Gadolinium DTPA
2
Exercise
2
Elasticity Imaging Techniques
2
Drug Therapy
2
Diffusion Tensor Imaging
2
Congresses as Topic
2
Aminolevulinic Acid
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
vandetanib
1
poly ICLC
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Glioma
×
Neuropsychological Tests
×
Clear all
NCT05727605
2024-05-08
NARCiS
Universitaire Ziekenhuizen KU Leuven
Phase NA
Recruiting
120 enrolled